Neoadjuvant metformin added to conventional chemotherapy synergizes anti-proliferative effects in ovarian cancer.

Kuo-Chang WenPi-Lin SungAlexander T H WuPing-Chieh ChouJun-Hung LinChi-Ying F HuangSai-Ching J YeungMong-Hong Lee

Published in: Journal of ovarian research (2020)

This study shows that neoadjuvant metformin at clinically relevant dosages is efficacious in treating ovarian cancer, and the results can be used to guide clinical trials.

Keyphrases

locally advanced
rectal cancer
clinical trial
lymph node
squamous cell carcinoma
radiation therapy
randomized controlled trial